The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent.
The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.
Objective: To reanalyze data from two previous studies to provide stronger evidence of benefit for early use of single-dose intravenous bolus salbutamol in children with acute severe exacerbations ...
In an attempt to stop the preterm labor from progressing, the obstetrician prescribed IV magnesium sulfate, with a bolus dose of 6 g over 30 minutes followed by a continuous infusion of 2 g/hour.
The author is looking forward to seeing how Beam Therapeutics would do in their clinical trials of single-base DNA editing.
A California company offering the world's first injectable CBD product is in hot water after the FDA said the IV injections ...
NAD infusions are just one of the latest crazes for longevity-seekers, but can it really help you live longer? Here’s what an ...
1d
IFLScience on MSNIV Bags Could Be Pumping Microplastics Straight Into The Bloodstream, Scientists SuggestMicroplastics get everywhere, and there’s increasing attention being paid to their potential effects on human health. It’s ...
(2) You are limited to two withdrawals a year or the rate drops (3) You are limited to three withdrawals a year or the rate drops (4) You are limited to four withdrawals a year or the rate drops ...
The 2015 American Heart Association (AHA) Guidelines Update for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC) made several new changes for pediatric care associated ...
A Tom Hardy action movie, a new Virgin River-style series and a hospital drama headlines the month’s lineup so far.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results